TCG Crossover
Investments by market, targeted sectors and preferred funding rounds
Investments by industry
biotech - 50%
healthtech - 50%
Number of investments: 2
TCG Crossover invested in Entrada Therapeutics during a round worth $116,000,000 - 3/31/2021
TCG Crossover invested in Aktis Oncology during a round worth $72,000,000 - 3/18/2021